Lexington, MA, United States of America

Macy Jin

USPTO Granted Patents = 4 


Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Macy Jin

Introduction: Macy Jin is a prominent inventor based in Lexington, MA, contributing significantly to the field of biotechnology. With a total of four patents to her name, she has made remarkable advances in medical science, particularly in the treatment of bleeding disorders.

Latest Patents: Among Macy Jin’s latest inventions is the patent on "Tissue factor pathway inhibitor antibodies and uses thereof." This invention involves antibodies and antigen-binding fragments that specifically bind to tissue factor pathway inhibitor (TFPI) and inhibit its activity. These innovative antibodies and fragments hold potential for treating bleeding disorders and reducing clotting time. This patent exemplifies Macy’s commitment to developing therapies that can profoundly impact patient care.

Career Highlights: Macy Jin’s career is marked by her work at Pfizer Corporation, where she continues to lead her research efforts in the development of groundbreaking medical therapies. Her dedication to innovation and excellence in her field is evident through her patent achievements and the relevance of her work in improving healthcare outcomes.

Collaborations: Macy collaborates with talented colleagues such as Zong Sean Juo and Matthew Holsti, which enhances her research capabilities. These partnerships illustrate the collaborative nature of scientific research, where combined expertise often leads to significant breakthroughs.

Conclusion: Inventor Macy Jin exemplifies the spirit of innovation in the biotechnology sector. Her patents, particularly related to TFPI-targeting antibodies, showcase her commitment to addressing critical health challenges. As she continues her work at Pfizer Corporation, her contributions will undoubtedly pave the way for new approaches to treating bleeding disorders and improving patient health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…